NewsRoom Articles - Page 625 of 1444

TuesdaySep 01, 2020 11:40 am

Medexus Pharmaceuticals Inc. (OTCQX: PDDPF) (TSX.V: MDP) Starts Presentation at The LD 500

Medexus Pharmaceutical Inc. (OTCQX: PDDPF) (TSX.V: MDP) is a leading specialty pharmaceutical company with a strong North American commercial platform. The company's vision is to provide the best health care products to health care professionals and patients, through its core values of quality, innovation, customer service and teamwork. Medexus Pharmaceuticals is focused on the therapeutic areas of auto-immune disease, hematology and allergy. The company's leading products are: Rasuvo(TM) and Metoject(R), a unique formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY(R), an intravenous recombinant factor IX therapeutic for use in patients 12…

TuesdaySep 01, 2020 11:40 am

Camtek Ltd. (NASDAQ: CAMT) (TASE: CAMT) Starts Presentation at The LD 500

Camtek Ltd. (NASDAQ: CAMT) (TASE: CAMT) is a leading manufacturer of metrology and inspection equipment and a provider of software solutions. Camtek serves the advanced packaging, memory, CMOS image sensors, MEMS, RF and other segments of the mid-end of the semiconductor industry. Headquartered in Israel, Camtek provides dedicated solutions and crucial yield-enhancement data, enabling manufacturers to improve yield and drive down production costs. With eight offices around the world, Camtek is a best-in-class sales and customer support organization, providing tailor-made solutions in line with customers' requirements. For more information, visit the company's website at www.camtek.com About The LD 500 The…

TuesdaySep 01, 2020 11:40 am

Caladrius Biosciences Inc. (NASDAQ: CLBS) Starts Presentation at The LD 500

Caladrius Biosciences Inc. (NASDAQ: CLBS) is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease. The company is developing a first-in-class cell therapy product that is based on the notion that the human body contains finely tuned mechanisms for self-repair. Caladrius Biosciences' technology leverages and enables these mechanisms in the form of specific cells, using formulations and modes of delivery unique to each medical indication. The company's current product candidates include CLBS119, a CD34+ cell therapy product candidate for the repair of lung damage found in patients with severe COVID-19 infection who…

TuesdaySep 01, 2020 11:40 am

Blueknight Energy Partners L.P. (NASDAQ: BKEP) (NASDAQ: BKEPP) Starts Presentation at The LD 500

Blueknight Energy Partners L.P. (NASDAQ: BKEP) (NASDAQ: BKEPP) owns and operates a diversified portfolio of complementary midstream energy assets, offering terminalling, storage, processing, gathering and transportation services. The company's strategically located assets allow Blueknight to be a leading provider of midstream services in the energy industry. Blueknight provides services to its customers by focusing on two operational areas: product terminalling (liquid asphalt and crude oil) and crude oil logistics (pipeline transportation and trucking). Blueknight customers include independent oil and gas producers, petroleum product wholesalers and distributors, refiners and energy traders. For more information, visit the company's website at www.bkep.com About…

TuesdaySep 01, 2020 11:20 am

WeedMD Inc. (TSX.V: WMD) (OTCQX: WDDMF) Starts Presentation at The LD 500

WeedMD Inc. (TSX.V: WMD) (OTCQX: WDDMF) is the publicly traded parent company of WeedMD RX Inc. and Starseed Medicinal Inc., federally licensed producers of cannabis products for both the medical and adult-use markets. The company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario, as well as CX Industries Inc., a wholly owned subsidiary which specializes in cannabis extraction from the company's fully licensed 26,000 square foot processing facility in Aylmer, Ontario. The company maintains strategic relationships in the seniors' market and supply agreements with Shoppers Drug Mart, as well as six provincial distribution…

TuesdaySep 01, 2020 11:20 am

Cinedigm Corp. (NASDAQ: CIDM) Starts Presentation at The LD 500

Cinedigm Corp. (NASDAQ: CIDM) is a leading independent entertainment studio in North America, widely recognized for its film/TV/digital production, digital cinema, OTT channels, and content and marketing distribution. For more than 20 years, Cinedigm has led the digital transformation of the entertainment industry. Today, Cinedigm entertains hundreds of millions of consumers around the globe by providing premium content, streaming channels and technology services to the world's largest media, technology and retail firms. For more information, visit the company's website at www.cinedigm.com About The LD 500 The LD 500 is the most ambitious project in LD Micro's 14-year history of leading…

TuesdaySep 01, 2020 11:20 am

NervGen Pharma Corp. (TSX.V: NGEN) (OTCQX: NGENF) Starts Presentation at The LD 500

NervGen Pharma Corp. (TSX.V: NGEN) (OTCQX: NGENF) is restoring life's potential by creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. The company is developing drugs for the treatment of spinal cord injury, multiple sclerosis and Alzheimer's disease. NervGen's platform technology targets protein tyrosine phosphatase sigma ("PTPσ"), a neural receptor that impedes nerve repair. Inhibition of the PTPσ receptor has been shown to promote regeneration and remyelination of damaged nerves, as well as improvement of nerve function in animal models for various medical conditions. For more information, visit the company's website at www.nervgen.com About The LD 500…

TuesdaySep 01, 2020 11:00 am

Super League Gaming Inc. (NASDAQ: SLGG) Starts Presentation at The LD 500

Super League Gaming Inc. (NASDAQ: SLGG) is a leading gaming community and content platform that gives everyday gamers multiple ways to connect and engage with others while enjoying the video games they love. Powered by proprietary technology systems, Super League offers players the ability to create gameplay-driven experiences they can share with friends, the opportunity to watch live streaming broadcasts and gameplay highlights across digital and social channels, and the chance to compete in events and challenges designed to celebrate victories and achievements across multiple skill levels. With gameplay and content offerings featuring more than a dozen of the top…

TuesdaySep 01, 2020 11:00 am

iCAD Inc. (NASDAQ: ICAD) Starts Presentation at The LD 500

iCAD Inc. (NASDAQ: ICAD) is a global medical technology leader providing innovative cancer detection and therapy solutions. The company works passionately to provide precise, powerful health care solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes. iCAD offers a comprehensive range of computer-aided detection (CAD) and workflow solutions to support rapid and accurate detection of breast and colorectal cancers. The comprehensive iCAD technology platforms include advanced hardware and software designed to support cancer detection and radiation therapy treatments. For more information, visit the company's website at www.icadmed.com About The LD 500 The LD 500 is the most…

TuesdaySep 01, 2020 11:00 am

Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Starts Presentation at The LD 500

Citius Pharmaceuticals Inc. (NASDAQ: CTXR) is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care. Citius is focused on the development and commercialization of important new drug products for growing markets. The company is currently advancing three proprietary product candidates: Mino-Lok(R), CITI-002 (halobetasol-lidocaine formulation) and CITI-101 (Mino-Wrap). Citius believes the markets for its products are large and underserved by the current standard of care. For more information, visit the company's website at www.citiuspharma.com About The LD 500 The LD 500 is the most ambitious project in…